BFSG LLC’s InMed Pharmaceuticals INM Stock Holding History

BFSG LLC’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10	Closed	-$73	–	646
2024 Q1	$73	Buy	+10	New	+$74	﹤0.01%	650

Other funds holding INM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

AWM

AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

BFSG LLC's INM Position: Q2 2024 in Review

BFSG LLC sold out of InMed Pharmaceuticals (INM) in Q2 2024, closing a stake of 10 shares — an estimated $73 sold.

BFSG LLC first reported a position in INM in Q1 2024 and held it in 1 quarter. The position peaked at $73 in Q1 2024. 11 funds tracked by Wall St. Rank hold INM as of Q2 2024.

BFSG LLC reported no remaining InMed Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
BFSG LLC sold 10 InMed Pharmaceuticals shares in Q2 2024, an estimated $73.
BFSG LLC first reported a position in InMed Pharmaceuticals in Q1 2024 and held it in 1 quarter.
BFSG LLC's InMed Pharmaceuticals position peaked at $73 in Q1 2024.
11 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2024.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.